Hysteroscopic management versus ultrasound-guided evacuation for women with first-trimester pregnancy loss, a randomised controlled trial

Hadeer Meshaal, Emad Salah, Eman Fawzy, Mazen Abdel-Rasheed, Ahmed Maged, Hany Saad, Hadeer Meshaal, Emad Salah, Eman Fawzy, Mazen Abdel-Rasheed, Ahmed Maged, Hany Saad

Abstract

Objective: We aimed to evaluate the hysteroscopic management of first-trimester pregnancy loss compared to surgical evacuation either blind or under ultrasonographic guidance‎.

Methods: This clinical trial included ‎315 women with first-trimester pregnancy loss, divided equally into three groups. Group 1 underwent traditional blind surgical evacuation, group 2 underwent ultrasound-guided evacuation, and group 3 underwent hysteroscopic management. All women were assessed for retained products, surgical complications, the need for further management, and pregnancy occurrence after evacuation within 2 years of follow up.

Results: The rate of presence of conception remnants and the need for further ‎treatment was significantly higher in group 1 compared to groups 2 and 3 (4.8% vs. 0% vs. 0%, P = 0.012). The conception rate within 2 years was significantly lower in group 1 compared to groups 2 and 3 (57.4% vs. 73.2% vs. 82.7%, P = 0.002), and the duration needed to conceive was significantly prolonged in group 1 compared to groups 2 and 3 (9.8 vs. 8.3 vs. 6.9 months, P < 0.001). Interestingly, women who underwent hysteroscopic management needed a significantly shorter time to conceive than those who underwent ultrasound-guided evacuation‎ (6.9 vs. 8.3 months, P = 0.006).

Conclusions: Hysteroscopic management of first-trimester pregnancy loss was superior to ultrasound-guided surgical evacuation regarding the time interval to conceive. Both techniques were superior to the blind evacuation technique regarding removal of the whole conception remnants, need for further treatment and fertility outcomes. Clinical trial registration: It was first registered at ClinicalTrials.gov on 16/03/2017 with registration number NCT03081104.

Keywords: Hysteroscopy; Missed miscarriage; Pregnancy loss; Surgical evacuation; Ultrasound-guided evacuation.

Conflict of interest statement

None of the authors has financial or other competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Flow of patients in the study

References

    1. Åhman E, Shah IH. Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008. Geneva: World Health Organization; 2011.
    1. Thomson AJ, Abbott JA, Deans R, Kingston A, Vancaillie TG. The management of intrauterine synechiae. Curr Opin Obstet Gynecol. 2009;21:335–41. doi: 10.1097/GCO.0b013e32832e07fc.
    1. Kripke C. Expectant management vs. surgical treatment for miscarriage. Am Fam Physician. 2006;74:1125.
    1. Tanha FD, Feizi M, Shariat M. Sublingual versus vaginal misoprostol for the management of missed abortion. J Obstet Gynaecol Res. 2010;36:525–32. doi: 10.1111/j.1447-0756.2010.01229.x.
    1. Morgentaler H. Report on 5641 outpatient abortions by vacuum suction curettage. Can Med Assoc J. 1973;109:1202.
    1. American College of Obstetricians and Gynecologists ACOG practice bulletin no. 200 summary: early pregnancy loss. Obstet Gynecol. 2018;132:1311–3. doi: 10.1097/AOG.0000000000002900.
    1. Ngai SW, Chan YM, Tang OS, Ho PC. The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration: a randomised trial. Hum Reprod. 1999;14:2139–42. doi: 10.1093/humrep/14.8.2139.
    1. American College of Obstetricians and Gynecologists ACOG practice bulletin no. 195: prevention of infection after gynecologic procedures. Obstet Gynecol. 2018;131:e172–89. doi: 10.1097/AOG.0000000000002670.
    1. Babarinsa AE, Babarinsa IA. Administration of Syntocinon by anesthetists at the time of uterine evacuation in early pregnancy. J Anaesthesiol Clin Pharmacol. 2017;33:549–50. doi: 10.4103/0970-9185.222513.
    1. Acharya G, Morgan H, Paramanantham L, Fernando R. A randomised controlled trial comparing surgical termination of pregnancy with and without continuous ultrasound guidance. Eur J Obstet Gynecol Reprod Biol. 2004;114:69–74. doi: 10.1016/j.ejogrb.2003.09.042.
    1. Hooker AB, Aydin H, Brölmann HA, Huirne JA. Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertil Steril. 2016;105:156–64. doi: 10.1016/j.fertnstert.2015.09.021.
    1. Condous G, Okaro E, Bourne T. The conservative management of early pregnancy complications: a review of the literature. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2003;22:420–30. doi: 10.1002/uog.236.
    1. Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial) Bmj. 2006;332:1235–40. doi: 10.1136/bmj.38828.593125.55.
    1. Hooker AB, Lemmers M, Thurkow AL, Heymans MW, Opmeer BC, Brölmann HA, et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update. 2014;20:262–78. doi: 10.1093/humupd/dmt045.
    1. Ben-Ami I, Melcer Y, Smorgick N, Schneider D, Pansky M, Halperin R. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception. Int J Gynecol Obstet. 2014;127:86–9. doi: 10.1016/j.ijgo.2014.05.003.
    1. Haber K, Hawkins E, Levie M, Chudnoff S. Hysteroscopic morcellation: review of the manufacturer and user facility device experience (MAUDE) database. J Minim Invasive Gynecol. 2015;22:110–4. doi: 10.1016/j.jmig.2014.08.008.
    1. Rein DT, Schmidt T, Hess AP, Volkmer A, Schöndorf T, Breidenbach M. Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage. J Minim Invasive Gynecol. 2011;18:774–8. doi: 10.1016/j.jmig.2011.08.003.
    1. Harpham M, Abbott J. Use of a hysteroscopic morcellator to resect miscarriage in a woman with recurrent Asherman’s syndrome. J Minim Invasive Gynecol. 2014;21:1118–20. doi: 10.1016/j.jmig.2014.05.006.
    1. Vitale SG, Riemma G, Carugno J, Perez-Medina T, Alonso Pacheco L, Haimovich S, et al. Postsurgical barrier strategies to avoid the recurrence of intrauterine adhesion formation after hysteroscopic adhesiolysis: a network meta-analysis of randomised controlled trials. Am J Obstet Gynecol. 2022;226:487–498.e8. doi: 10.1016/j.ajog.2021.09.015.
    1. Golan A, Dishi M, Shalev A, Keidar R, Ginath S, Sagiv R. Operative hysteroscopy to remove retained products of conception: novel treatment of an old problem. J Minim Invasive Gynecol. 2011;18:100–3. doi: 10.1016/j.jmig.2010.09.001.
    1. Capmas P, Lobersztajn A, Duminil L, Barral T, Pourcelot A-G, Fernandez H. Operative hysteroscopy for retained products of conception: efficacy and subsequent fertility. J Gynecol Obstet Hum Reprod. 2019;48:151–4. doi: 10.1016/j.jogoh.2018.12.005.
    1. Caserta L, Labriola D, Torella M, Di Caterina B. The use of transvaginal ultrasound following voluntary interruption of pregnancy to reduce complications due to incomplete curettage. Minerva Ginecol. 2008;60:7–13.
    1. Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z. Hysteroscopic management of retained products of conception: meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol. 2014;173:19–22. doi: 10.1016/j.ejogrb.2013.11.020.
    1. Sotiriadis A, Makrydimas G, Papatheodorou S, Ioannidis JP. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis. Obstet Gynecol. 2005;105:1104–13. doi: 10.1097/01.AOG.0000158857.44046.a4.
    1. Cohen SB, Kalter-Ferber A, Weisz BS, Zalel Y, Seidman DS, Mashiach S, et al. Hysteroscopy may be the method of choice for management of residual trophoblastic tissue. J Am Assoc Gynecol Laparosc. 2001;8:199–202. doi: 10.1016/S1074-3804(05)60577-4.
    1. Vitale SG, Parry JP, Carugno J, Cholkeri-Singh A, Della Corte L, Cianci S, et al. Surgical and reproductive outcomes after hysteroscopic removal of retained products of conception: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021;28:204–17. doi: 10.1016/j.jmig.2020.10.028.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi